PKP-029 Pharmacogenetic study of the influence of polymorphisms in the tnfr1a and fas genes on the response to rituximab and chemotherapy in follicular lymphoma patients

MDR Gutiérrez Cívicos; P Conesa Zamora; I Español Morales; D Gutiérrez-Meca Maestre; AC Viney; I Muñoz García; MH García Lagunar; A García Márquez; R Guerrero Bautista; E Ferris Villanueva

doi:10.1136/ejhpharm-2016-000875.432

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Pharmacokinetics and pharmacodynamics

PKP-029 Pharmacogenetic study of the influence of polymorphisms in the tnfr1a and fas genes on the response to rituximab and chemotherapy in follicular lymphoma patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Cívicos MG, Zamora PC, Morales IE, et al

PKP-029 Pharmacogenetic study of the influence of polymorphisms in the tnfr1a and fas genes on the response to rituximab and chemotherapy in follicular lymphoma patients

European Journal of Hospital Pharmacy 2016;23:A191.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password